Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, including …
A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of…
Cancer vaccine research seems to be having a moment. Are recent advances a leap forward or is it too soon to tell?
Research on so-called mirror cells, which defy fundamental properties of living organisms, should be prohibited as too dangerous, biologists said.
According to the Surveillance, Epidemiology, and End Results Program registry, approximately 36,000 patients are annually diagnosed with multiple m…
Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma which is often characterised by a pattern of continued relapse after frontline chemoimmunotherapy. Although patients…
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial / Avelumab, axitinib, cancer, ESMO Annals of Oncology, Javelin Renal 101 trial, OncoDaily,
This review summarises the cytomorphological and immunophenotypical alterations characteristic of myeloid neoplasms with defining genetic alterations, including the examples in the image. These cytol…
